Jacqueline Bryant, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 545 Stonecrest Pkwy, Smyrna, TN 37167 Phone: 931-551-1795 Fax: 931-551-1798 |
Kari Slukich, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 545 Stonecrest Pkwy, Smyrna, TN 37167 Phone: 615-220-3720 |
Sarah Sowell, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 200 Stonecrest Blvd, Smyrna, TN 37167 Phone: 615-768-2000 |
Peggy Kerres Leonard, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 200 Stonecrest Blvd, Smyrna, TN 37167 Phone: 615-768-2000 |
Lisa B Hammock, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 545 Stonecrest Pkwy, Smyrna, TN 37167 Phone: 931-551-1795 Fax: 931-551-1798 |
Victor Paul Dec, Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 200 Stonecrest Blvd, Smyrna, TN 37167 Phone: 615-768-2000 |
Ellen Colleen Ritter, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 545 Stonecrest Pkwy, Smyrna, TN 37167 Phone: 931-551-1795 Fax: 931-551-1798 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has initiated Phase 1 clinical studies for ISIS-GCGRRx and ISIS-GCCRRx, antisense drugs Isis is developing for the treatment of type 2 diabetes.
The National Institutes of Health has awarded Dr. Daniel Geschwind, director of the UCLA Center for Autism Research and Treatment, a five-year, $10 million grant to continue his research on the genetic causes of autism spectrum disorders and to expand his investigations to include the genetics of autism in African Americans.
A workplace program designed to teach employees to act more like consumers when they make health care decisions, for example, by finding and evaluating health information or choosing a benefit plan, also improved exercise, diet and other health habits, according to a new study in the latest issue of the American Journal of Health Promotion.
Life Technologies Corporation today announced the acquisition of Navigenics, Inc. This acquisition represents Life Technologies' first step in executing against a strategy to build out its molecular diagnostics business through internal development, partnerships and select acquisitions.
The ruling by the Supreme Court to uphold most of the health law has put the controversy squarely back on the parties' agendas for the November elections.
› Verified 4 days ago